{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:16:56Z","timestamp":1787728616820,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011132","name":"Rutgers The State University of New Jersey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtm.2025.101587","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:46:06Z","timestamp":1756914366000},"page":"101587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated tripeptidyl-peptidase 1 corrects multiple disease phenotypes in a mouse model of juvenile neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"33","author":[{"given":"Whitney","family":"Banach-Petrosky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Larrimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Sleat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Bazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin K.","family":"Ichida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd P.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-2471","authenticated-orcid":false,"given":"Peter","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-9928","authenticated-orcid":false,"given":"David E.","family":"Sleat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101587_bib1","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"444","author":"Mole","year":"2011"},{"key":"10.1016\/j.omtm.2025.101587_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.811686","article-title":"Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview","volume":"13","author":"Simonati","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2025.101587_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ajmg.1320420428","article-title":"Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)","volume":"42","author":"Palmer","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtm.2025.101587_bib4","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.bbadis.2015.06.014","article-title":"The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs)","volume":"1852","author":"Palmer","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2025.101587_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/oxfordjournals.jbchem.a022781","article-title":"Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase","volume":"128","author":"Ezaki","year":"2000","journal-title":"J. Biochem."},{"key":"10.1016\/j.omtm.2025.101587_bib6","first-page":"211","article-title":"Lysosomal storage of the DCCD reactive proteolipid subunit of mitochondrial ATP synthase in human and ovine ceroid lipofuscinoses","volume":"266","author":"Palmer","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtm.2025.101587_bib7","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101587_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3","volume":"82","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101587_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41586-022-05221-y","article-title":"CLN3 is required for the clearance of glycerophosphodiesters from lysosomes","volume":"609","author":"Laqtom","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101587_bib10","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101587_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101587_bib12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jimd.12619","article-title":"A mouse mutant deficient in both neuronal ceroid lipofuscinosis-associated proteins CLN3 and TPP1","volume":"46","author":"Sleat","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2025.101587_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(99)00095-6","article-title":"Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases","volume":"264","author":"Junaid","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtm.2025.101587_bib14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/302427","article-title":"Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder","volume":"64","author":"Sleat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101587_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192286","article-title":"Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Nemtsova","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101587_bib16","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","article-title":"Cln3(Delta ex7\/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth","volume":"11","author":"Cotman","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101587_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2007.08.017","article-title":"Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"29","author":"Katz","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101587_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1242\/dmm.018804","article-title":"Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender","volume":"8","author":"Kovacs","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2025.101587_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.886567","article-title":"Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses","volume":"13","author":"Takahashi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2025.101587_bib20","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2025.101587_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3-\/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"Pontikis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2025.101587_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtm.2025.101587_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41436-020-01035-3","article-title":"Neurofilament light chain levels correlate with clinical measures in CLN3 disease","volume":"23","author":"Dang Do","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2025.101587_bib24","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1021\/acs.jproteome.3c00199","article-title":"Cerebrospinal Fluid Protein Biomarker Discovery in CLN3","volume":"22","author":"Dang Do","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.omtm.2025.101587_bib25","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101587_bib26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF00607283","article-title":"MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis","volume":"38","author":"Autti","year":"1996","journal-title":"Neuroradiology"},{"key":"10.1016\/j.omtm.2025.101587_bib27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00415-008-0891-x","article-title":"JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence","volume":"255","author":"Autti","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.omtm.2025.101587_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ejpn.2000.0444","article-title":"High resolution MRI reveals global changes in brains of Cln3 mutant mice","volume":"5","author":"Greene","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omtm.2025.101587_bib29","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.bbadis.2013.01.019","article-title":"Cell biology and function of neuronal ceroid lipofuscinosis-related proteins","volume":"1832","author":"Kollmann","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2025.101587_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218055","article-title":"Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease","volume":"21","author":"Shematorova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101587_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2202-5-57","article-title":"Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis","volume":"5","author":"Fossale","year":"2004","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.omtm.2025.101587_bib32","first-page":"7060","article-title":"Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Deltaex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"24","author":"Wavre-Shapton","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101587_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165883","article-title":"Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium","volume":"1866","author":"Zhong","year":"2020","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.omtm.2025.101587_bib34","doi-asserted-by":"crossref","first-page":"20483","DOI":"10.1074\/jbc.M602180200","article-title":"Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"281","author":"Cao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101587_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121531","article-title":"An Autophagy Modifier Screen Identifies Small Molecules Capable of Reducing Autophagosome Accumulation in a Model of CLN3-Mediated Neurodegeneration","volume":"8","author":"Petcherski","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2025.101587_bib36","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1523\/JNEUROSCI.2447-21.2023","article-title":"Activation of PPARalpha exhibits therapeutic efficacy in a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"43","author":"Jana","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101587_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013742","article-title":"Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype","volume":"13","author":"Soldati","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2025.101587_bib38","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.molcel.2024.02.006","article-title":"Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten disease","volume":"84","author":"Nyame","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtm.2025.101587_bib39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2006.11.006","article-title":"Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B","volume":"90","author":"Ryazantsev","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2025.101587_bib40","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1074\/jbc.M114.621706","article-title":"Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function","volume":"290","author":"Chandrachud","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101587_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1471-4159.2010.07158.x","article-title":"Lithium rescues the impaired autophagy process in CbCln3(Deltaex7\/8\/Deltaex7\/8) cerebellar cells and reduces neuronal vulnerability to cell death via IMPase inhibition","volume":"116","author":"Chang","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omtm.2025.101587_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055526","article-title":"Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts","volume":"8","author":"Vidal-Donet","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101587_bib43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-017-0771-8","article-title":"Cerliponase Alfa: First Global Approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.omtm.2025.101587_bib44","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of Intraventricular Cerliponase Alfa for CLN2 Disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101587_bib45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/hum.2023.067","article-title":"Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease","volume":"34","author":"De","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101587_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s004010050629","article-title":"Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders","volume":"93","author":"Elleder","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtm.2025.101587_bib48","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Xu","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101587_bib49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neurobiolaging.2022.06.012","article-title":"Elevated levels of tripeptidyl peptidase 1 do not ameliorate pathogenesis in a mouse model of Alzheimer disease","volume":"118","author":"Sleat","year":"2022","journal-title":"Neurobiol. Aging"}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:32:20Z","timestamp":1776198740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2329050125001822"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101587","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated tripeptidyl-peptidase 1 corrects multiple disease phenotypes in a mouse model of juvenile neuronal ceroid lipofuscinosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101587"}}